Cue Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cue Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2021 to Q2 2024.
  • Cue Biopharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 50.2M shares, a 12% increase year-over-year.
  • Cue Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 45.8M shares, a 28.3% increase from 2022.
  • Cue Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 35.6M shares, a 13.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 50.2M +5.38M +12% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 49.5M +4.81M +10.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 45.8M +10.1M +28.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 46.4M +11M +31% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 44.8M +9.44M +26.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 44.7M +12M +36.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 35.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 35.4M +4.07M +13% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 35.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 32.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 31.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.